107 related articles for article (PubMed ID: 26763403)
1. Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids.
Takagi M; Sanoh S; Santoh M; Ejiri Y; Kotake Y; Ohta S
J Toxicol Sci; 2016 Feb; 41(1):155-64. PubMed ID: 26763403
[TBL] [Abstract][Full Text] [Related]
2. Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE.
Bhandari N; Figueroa DJ; Lawrence JW; Gerhold DL
Assay Drug Dev Technol; 2008 Jun; 6(3):407-19. PubMed ID: 18537465
[TBL] [Abstract][Full Text] [Related]
3. A cell-based assay using HepaRG cells for predicting drug-induced phospholipidosis.
Tomida T; Ishimura M; Iwaki M
J Toxicol Sci; 2017; 42(5):641-650. PubMed ID: 28904299
[TBL] [Abstract][Full Text] [Related]
4. Validation of an in vitro screen for phospholipidosis using a high-content biology platform.
Morelli JK; Buehrle M; Pognan F; Barone LR; Fieles W; Ciaccio PJ
Cell Biol Toxicol; 2006 Jan; 22(1):15-27. PubMed ID: 16463016
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the phospholipidogenic potential of 4(1H)-pyridone antimalarial derivatives.
Almela MJ; Torres PA; Lozano S; Herreros E
Toxicol In Vitro; 2009 Dec; 23(8):1528-34. PubMed ID: 19540329
[TBL] [Abstract][Full Text] [Related]
6. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
Miyamoto S; Matsumoto A; Mori I; Horinouchi A
Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte spheroids as a viable
Chacko SA; Ly VT; Christopher LJ; Gan J
Xenobiotica; 2020 Jun; 50(6):621-629. PubMed ID: 31566996
[TBL] [Abstract][Full Text] [Related]
8. Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis.
Zhang X; Yang L; Liu Y; Song Z; Zhao J; Chen D; Yu H; Li R; Wang Y; Yang K; Chen Y; Xia M; Zhang LW
Toxicol Appl Pharmacol; 2018 Jun; 348():54-66. PubMed ID: 29678448
[TBL] [Abstract][Full Text] [Related]
9. Fluorometric assessment of acetaminophen-induced toxicity in rat hepatocyte spheroids seeded on micro-space cell culture plates.
Sanoh S; Santoh M; Takagi M; Kanayama T; Sugihara K; Kotake Y; Ejiri Y; Horie T; Kitamura S; Ohta S
Toxicol In Vitro; 2014 Sep; 28(6):1176-82. PubMed ID: 24878114
[TBL] [Abstract][Full Text] [Related]
10. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies.
Nioi P; Perry BK; Wang EJ; Gu YZ; Snyder RD
Toxicol Sci; 2007 Sep; 99(1):162-73. PubMed ID: 17567588
[TBL] [Abstract][Full Text] [Related]
11. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier.
Yang L; Zhong X; Li Q; Zhang X; Wang Y; Yang K; Zhang LW
Toxicol Sci; 2017 Mar; 156(1):39-53. PubMed ID: 28013220
[TBL] [Abstract][Full Text] [Related]
12. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG
Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975
[TBL] [Abstract][Full Text] [Related]
13. Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte-hepatic stellate cell interactions and flow effects.
Lee SA; No da Y; Kang E; Ju J; Kim DS; Lee SH
Lab Chip; 2013 Sep; 13(18):3529-37. PubMed ID: 23657720
[TBL] [Abstract][Full Text] [Related]
14. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W
Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938
[TBL] [Abstract][Full Text] [Related]
15. Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing.
Tostões RM; Leite SB; Serra M; Jensen J; Björquist P; Carrondo MJ; Brito C; Alves PM
Hepatology; 2012 Apr; 55(4):1227-36. PubMed ID: 22031499
[TBL] [Abstract][Full Text] [Related]
16. Adaptation of an in vitro phospholipidosis assay to an automated image analysis system.
Schurdak ME; Vernetti LA; Abel SJ; Thiffault C
Toxicol Mech Methods; 2007; 17(2):77-86. PubMed ID: 20020975
[TBL] [Abstract][Full Text] [Related]
17. Identification of hepatic phospholipidosis inducers in sandwich-cultured rat hepatocytes, a physiologically relevant model, reveals altered basolateral uptake and biliary excretion of anionic probe substrates.
Ferslew BC; Brouwer KL
Toxicol Sci; 2014 May; 139(1):99-107. PubMed ID: 24563379
[TBL] [Abstract][Full Text] [Related]
18. Mixed-ligand modification of polyamidoamine dendrimers to develop an effective scaffold for maintenance of hepatocyte spheroids.
Higashiyama S; Noda M; Kawase M; Yagi K
J Biomed Mater Res A; 2003 Mar; 64(3):475-82. PubMed ID: 12579561
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the risk of phospholipidosis using a new multidisciplinary pipeline approach.
Goracci L; Buratta S; Urbanelli L; Ferrara G; Di Guida R; Emiliani C; Cross S
Eur J Med Chem; 2015 Mar; 92():49-63. PubMed ID: 25544686
[TBL] [Abstract][Full Text] [Related]
20. In vitro validation of drug-induced phospholipidosis.
Park S; Choi YJ; Lee BH
J Toxicol Sci; 2012; 37(2):261-7. PubMed ID: 22467016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
